Yael Gruenbaum-Cohen is a Partner & Head of aMoon Alpha at aMoon Fund, where they focus on HealthTech investments in Israel across early-stage, late-stage/growth, and Series A and later. They have invested in companies including Lutris Pharma. Previously, they were a Venture Partner at aMoon Fund; Chief Executive Officer of Andlit Therapeutics; General Manager and earlier Analyst & Director at Medison Ventures (Medison Pharma); Medical Manager at Medison Pharma; served in Standards and Registration at the Ministry of Health Israel; were a Postdoctoral Fellow in Molecular Genetics at the Weizmann Institute of Science; and worked in Maxillofacial Rehabilitation at Hadassah Medical Centers / The Hebrew University. Yael graduated from The Hebrew University of Jerusalem and resides in the Jerusalem District, Israel.
Yael Gruenbaum-Cohen, Partner @ aMoon. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Yael Gruenbaum-Cohen from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Yael
Map your path to Yael instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Yael
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.